Bromocriptine prevents spinal motor neuron death following sciatic nerve transection in neonatal rats

Neuroscience Letters

Volumn 214, Issue 2-3, 1996, Pages 139-142

  Iwasaki, Yasuo ^a   Shiojima, Toshiya ^a   Ikeda, Ken ^a   Kinoshita, Masao ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Axotomy induced motor neuron death; Bromocriptine; Motor neuron disease; Neuroprotection; Spinal motor neuron

Indexed keywords

BROMOCRIPTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTONEURON; NERVE CELL NECROSIS; NERVE TRANSECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0030598968     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12907-4     Document Type: Article

References (25)

1. 3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats, J. Pharmacol. Exp. Ther., 252 (1990) 901-907.
2. [2] Clow, A., Hussain, T., Glover, V., Sandler, M., Dexter, D.J. and Walker, M., (-)-Deprenyl can induce soluble superoxide dismutase in rat striata, J. Neural. Transm., 86 (1991) 77-80.
3. 2 receptor in rat spinal cord identified with immunocytochemical and in situ hybridization, Eur. J. Neurosci., 8 (1996) 621-628.
4. [4] Felten, D.L., Felten, S.Y., Fuller, R.W., Romano, T.D., Smalstig, E.B., Wong, D.T. and Clemen, J.A., Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats, Neurobiol. Ageing, 13 (1992) 339-351.
5. [5] Iwasaki, Y., Ikeda, R. and Kinoshita, M., Decreased cerebrospinal fluid superoxide dismutase in amyotrophic lateral sclerosis, Lancet, 342 (1993) 1118.
6. [6] Iwasaki, Y., Ikeda, R., Shiojima, T. and Kinoshita, M., The effect of pergolide and deprenyl on axotomy-induced cell death in the spinal motor neuron of the rat, Ann. Neurol., 36 (1994) 282-283.
7. [7] Iwasaki, Y., Ikeda, R., Shiotima, T. and Kinoshita, M., CNQX prevents spinal motor neuron death following sciatic nerve transection in newborn rats, J. Neurol. Sci., 134 (1995) 21-25.
8. [8] Liu, X.-H., Rato, H., Chen, T., Rato, K. and Itoyama, Y., Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil, J. Neurol. Sci., 129 (1995) 9-14.
9. [9] Mitsumoto, H., Ikeda, K., Rlinkosz, B., Cedarbaum, J.M., Wong, V. and Lindsay, R.M., Arrest of motoneuron disease in wobbler mice cotreated with CNTF and BDNF, Science, 265 (1994) 1107-1110.
10. [10] Neff, N.T., Prevette, D., Houenou, L.J., Lewis, M.E., Glicksman, M.A., Yin, Q.W. and Oppenheim, R.W., Insulin-like growth factors-putative muscle-derived trophic agents that promote motoneuron survival, J. Neurobiol., 24 (1993) 1578-1588.
11. [11] Nicolopoulos-Stournaras, S. and Iles, J.F., Motor neuron columns in the lumbar spinal cord of the rat, J. Comp. Neurol., 217 (1983) 75-85.
12. [12] Nishi, R., Neurotrophic factors: two are better than one, Science, 265 (1994) 1052-1053.
13. [13] Ogawa, N., Tanaka, R., Asanuma, M., Rawal, M., Masumizu, T., Rohno, M. and Mori, A., Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vivo, Brain Res., 657 (1994) 207-213.
14. [14] Olanow, C.W., A radical hypothesis for neurodegeneration, Trends Neurosci., 16 (1993) 439-444.
15. [15] Oppenheim, R.W., The absence of significant postnatal motoneuron death in the brachial and lumbar spinal cord of the rat, J. Comp. Neurol., 246 (1986) 281-286.
16. [16] Rosen, D.R., Siddique, D. and Patterson, D. et al., Mutation in Cu/ Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362 (1993) 59-62.
17. [17] Salo, P.T. and Tatton, W.G., Deprenyl reduces the death of motoneurons caused by axotomy, J. Neurosci. Res., 31 (1992) 394-400.
18. [18] Schmalbruch, H. and Rosenthal, A., Neurotrophin-4/5 postpones the death of injured spinal motoneurons in newborn rats, Brain Res., 700 (1995) 254-260.
19. [19] Sendtner, M., Rreutzberg, G.W. and Thoenen, H., Ciliary neurotrophic factor prevents the degeneration of motor neuron after axotomy, Nature, 345 (1990) 440-441.
20. [20] Snider, W.D., Elliott, J.L. and Yan, Q., Axotomy-induced neuronal death during development, J. Neurobiol., 23 (1992) 1231-1246.
21. [21] Umemiya, M., Araki, I. and Kuno, M., Electrophysiological properties of axotomized facial motoneurons that destined to die in neonatal rats, J. Physiol., 462 (1993) 661-678.
22. [22] Yan, Q., Snider, W.D., Pinzone, J.J. and Johnson, E.M. Jr., Retrograde transport of nerve growth factor (NGF) in motoneurons of developing rats: assessment of potential neurotrophic effects, Neuron, 1 (1988) 335-343.
23. [23] Yan, Q., Elliot, J. and Snider, W.D., Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death, Nature, 360 (1992) 753-755.
24. [24] Yan, Q., Matheson, C. and Lopez, O., In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons, Nature, 373 (1995) 341-344.
25. [25] Yoshikawa, T., Minamiyama, Y., Naito, Y. and Rondo, M., Antioxidant properties of bromocriptine, a dopamine agonist, J. Neurochem., 62 (1994) 1034-1038